Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › DDX43 as a biomarker of resistance to MEK1/2 inhibitors

DDX43 as a biomarker of resistance to MEK1/2 inhibitors

US Patent 10400285 · Granted Sep 3, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of preventing cancer metastasis2024
Methods of preventing cancer metastasis2024
Methods and compositions for treating cancer using peptide nucleic acid-based ag2022
Methods and compositions for treating cancer using peptide nucleic acid-based ag2020
Methods and compositions for treating cancer using peptide nucleic acid-based ag2018
Companion diagnostic for CDK4 inhibitors2018
Combination of bryostatin and paclitaxel for treating cancer2006
Combinations of PKC inhibitors and therapeutic agents for treating cancers2002
Combinations of PKC inhibitors and therapaeutic agents for treating cancers1998